Netskope, Inc. (NTSK) Spending and interest coverage
- R&D / revenue · 12 months: Value 71.74%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value 79.43%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 71.74% | Research and development expense / revenue. Period ending 2026-07-31. $575.79M ÷ $802.64M × 100 ≈ 71.74% |
| Stock-based compensation / revenue · 12 months | 79.43% | Share-based compensation / revenue. Period ending 2026-07-31. $637.55M ÷ $802.64M × 100 ≈ 79.43% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 575.79M USD | Research and Development Expense |
| Revenue | 802.64M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 637.55M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -759.79M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $575.79M | $802.64M | $637.55M | $-759.79M | (m) | 71.74% | 79.43% | (m) | (m) |
| 2026-04-30 | $546.86M | $752.85M | $582.13M | $-715.96M | (m) | 72.64% | 77.32% | (m) | (m) |
| 2026-01-31 | $509.03M | $709.00M | $516.19M | $-652.58M | (m) | 71.80% | 72.81% | (m) | (m) |
| 2025-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-01-31 | $254.19M | $538.27M | $50.83M | $-255.74M | (m) | 47.22% | 9.44% | (m) | (m) |
| 2024-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-01-31 | $224.50M | $406.88M | $60.99M | $-312.80M | (m) | 55.17% | 14.99% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.